Scarica l'app Stockscreener
1.09
0.91%
-0.01
Cytomx Therapeutics Inc Azioni (CTMX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
55.83%
41.46
|
26.61 | 26.38 | 24.72 | 23.50 |
Operating Expenses
|
9.53%
29.81
|
27.21 | 23.26 | 28.07 | 29.15 |
| Benefits Costs and Expenses |
11.83%
27.62
|
24.70 | 20.57 | - | 26.81 |
| Costs And Expenses |
11.83%
27.62
|
24.70 | 20.57 | 28.07 | 26.81 |
| Operating Income/Loss |
2,024%
11.66
|
-0.606 | 3.123 | -3.348 | -5.653 |
| Income/Loss From Continuing Operations Before Tax |
626.13%
13.84
|
1.906 | 5.815 | -1.087 | -3.311 |
| Income Tax Expense/Benefit |
95.42%
0.049
|
1.069 | 2.823 | - | - |
| Income/Loss From Continuing Operations After Tax |
1,548%
13.79
|
0.837 | 2.992 | -1.087 | -3.311 |
|
Net Income/Loss
|
1,548%
13.79
|
0.837 | 2.992 | -1.087 | -3.311 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,076%
82.03
|
2.5828 | 80.73 | 66.54 | 66.25 |
| Diluted Average Shares |
3,099%
82.63
|
2.5828 | 80.99 | 66.54 | 66.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):